MapLight Therapeutics, Inc.
Key Metrics
Market Snapshot
About
Clinical-stage biopharmaceutical company developing novel therapies for neuroscience and rare diseases. Pipeline targets mechanisms including cellular plasticity and neurodegeneration. Focus on conditions with high unmet medical need and limited treatment options.